Cargando…

Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts

Background: Survival from melanoma is strongly related to patient sex, with females having a survival rate almost twice that of males. Many explanations have been proposed but have not withstood critical scrutiny. Prior analysis of different cancers with a sex bias has identified six X-linked genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Emran, Abdullah Al, Nsengimana, Jérémie, Punnia-Moorthy, Gaya, Schmitz, Ulf, Gallagher, Stuart J., Newton-Bishop, Julia, Tiffen, Jessamy C., Hersey, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464825/
https://www.ncbi.nlm.nih.gov/pubmed/32731355
http://dx.doi.org/10.3390/cancers12082082
_version_ 1783577452567592960
author Emran, Abdullah Al
Nsengimana, Jérémie
Punnia-Moorthy, Gaya
Schmitz, Ulf
Gallagher, Stuart J.
Newton-Bishop, Julia
Tiffen, Jessamy C.
Hersey, Peter
author_facet Emran, Abdullah Al
Nsengimana, Jérémie
Punnia-Moorthy, Gaya
Schmitz, Ulf
Gallagher, Stuart J.
Newton-Bishop, Julia
Tiffen, Jessamy C.
Hersey, Peter
author_sort Emran, Abdullah Al
collection PubMed
description Background: Survival from melanoma is strongly related to patient sex, with females having a survival rate almost twice that of males. Many explanations have been proposed but have not withstood critical scrutiny. Prior analysis of different cancers with a sex bias has identified six X-linked genes that escape X chromosome inactivation in females and are, therefore, potentially involved in sex differences in survival. Four of the genes are well-known epigenetic regulators that are known to influence the expression of hundreds of other genes and signaling pathways in cancer. Methods: Survival and interaction analysis were performed on the skin cutaneous melanoma (SKCM) cohort in The Cancer Genome Atlas (TCGA), comparing high vs. low expression of KDM6A, ATRX, KDM5C, and DDX3X. The Leeds melanoma cohort (LMC) on 678 patients with primary melanoma was used as a validation cohort. Results: Analysis of TCGA data revealed that two of these genes—KDM6A and ATRX—were associated with improved survival from melanoma. Tumoral KDM6A was expressed at higher levels in females and was associated with inferred lymphoid infiltration into melanoma. Gene set analysis of high KDM6A showed strong associations with immune responses and downregulation of genes associated with Myc and other oncogenic pathways. The LMC analysis confirmed the prognostic significance of KDM6A and its interaction with EZH2 but also revealed the expression of KDM5C and DDX3X to be prognostically significant. The analysis also confirmed a partial correlation of KDM6A with immune tumor infiltrates. Conclusion: When considered together, the results from these two series are consistent with the involvement of X-linked epigenetic regulators in the improved survival of females from melanoma. The identification of gene signatures associated with their expression presents insights into the development of new treatment initiatives but provides a basis for exploration in future studies.
format Online
Article
Text
id pubmed-7464825
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74648252020-09-04 Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts Emran, Abdullah Al Nsengimana, Jérémie Punnia-Moorthy, Gaya Schmitz, Ulf Gallagher, Stuart J. Newton-Bishop, Julia Tiffen, Jessamy C. Hersey, Peter Cancers (Basel) Article Background: Survival from melanoma is strongly related to patient sex, with females having a survival rate almost twice that of males. Many explanations have been proposed but have not withstood critical scrutiny. Prior analysis of different cancers with a sex bias has identified six X-linked genes that escape X chromosome inactivation in females and are, therefore, potentially involved in sex differences in survival. Four of the genes are well-known epigenetic regulators that are known to influence the expression of hundreds of other genes and signaling pathways in cancer. Methods: Survival and interaction analysis were performed on the skin cutaneous melanoma (SKCM) cohort in The Cancer Genome Atlas (TCGA), comparing high vs. low expression of KDM6A, ATRX, KDM5C, and DDX3X. The Leeds melanoma cohort (LMC) on 678 patients with primary melanoma was used as a validation cohort. Results: Analysis of TCGA data revealed that two of these genes—KDM6A and ATRX—were associated with improved survival from melanoma. Tumoral KDM6A was expressed at higher levels in females and was associated with inferred lymphoid infiltration into melanoma. Gene set analysis of high KDM6A showed strong associations with immune responses and downregulation of genes associated with Myc and other oncogenic pathways. The LMC analysis confirmed the prognostic significance of KDM6A and its interaction with EZH2 but also revealed the expression of KDM5C and DDX3X to be prognostically significant. The analysis also confirmed a partial correlation of KDM6A with immune tumor infiltrates. Conclusion: When considered together, the results from these two series are consistent with the involvement of X-linked epigenetic regulators in the improved survival of females from melanoma. The identification of gene signatures associated with their expression presents insights into the development of new treatment initiatives but provides a basis for exploration in future studies. MDPI 2020-07-28 /pmc/articles/PMC7464825/ /pubmed/32731355 http://dx.doi.org/10.3390/cancers12082082 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Emran, Abdullah Al
Nsengimana, Jérémie
Punnia-Moorthy, Gaya
Schmitz, Ulf
Gallagher, Stuart J.
Newton-Bishop, Julia
Tiffen, Jessamy C.
Hersey, Peter
Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
title Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
title_full Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
title_fullStr Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
title_full_unstemmed Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
title_short Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
title_sort study of the female sex survival advantage in melanoma—a focus on x-linked epigenetic regulators and immune responses in two cohorts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464825/
https://www.ncbi.nlm.nih.gov/pubmed/32731355
http://dx.doi.org/10.3390/cancers12082082
work_keys_str_mv AT emranabdullahal studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts
AT nsengimanajeremie studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts
AT punniamoorthygaya studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts
AT schmitzulf studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts
AT gallagherstuartj studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts
AT newtonbishopjulia studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts
AT tiffenjessamyc studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts
AT herseypeter studyofthefemalesexsurvivaladvantageinmelanomaafocusonxlinkedepigeneticregulatorsandimmuneresponsesintwocohorts